Lupin to buy 5 drug brands from Menarini
Friday, 22 September 2023
Lupin is set to acquire five legacy pharmaceutical brands, including Piclin, Menoctyl, Sucramal O, Pyridium, and Distaclor, in the fields of gastroenterology, urology, and anti-infectives from Menarini, along with trademark rights. The deal, valued at approximately Rs 100 crore, was announced through a BSE filing, with no further financial details disclosed.
Lupin is set to acquire five legacy pharmaceutical brands, including Piclin, Menoctyl, Sucramal O, Pyridium, and Distaclor, in the fields of gastroenterology, urology, and anti-infectives from Menarini, along with trademark rights. The deal, valued at approximately Rs 100 crore, was announced through a BSE filing, with no further financial details disclosed.
|
||||
|
||||
You Might Like |